• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素修饰的金纳米粒子作为一种有前途的抗利什曼原虫纳米偶联物的研制。

Development of Amphotericin B Decorated Gold Nanoparticles as a Promising Antileishmanial Nanoconjugate.

机构信息

Biological and Life Sciences, School of Arts and Sciences, Central Campus, Ahmedabad University, Navrangpura, Ahmedabad, Gujarat 380009, India.

National Institute of Animal Biotechnology (NIAB), Opposite Journalist Colony, Near Gowlidoddy, Extended Q-City Road, Gachibowli, Hyderabad - 500032, Telangana, India.

出版信息

ACS Appl Bio Mater. 2024 Sep 16;7(9):6239-6248. doi: 10.1021/acsabm.4c00835. Epub 2024 Aug 18.

DOI:10.1021/acsabm.4c00835
PMID:39155492
Abstract

Leishmaniasis, attributed to the protozoan parasite , manifests in diverse clinical forms, including cutaneous, mucocutaneous, and visceral leishmaniasis; VL constitutes a significant global health menace. Prevalent in tropical and subtropical regions, this affliction disproportionately impacts individuals below the poverty threshold, transmitted through the bite of female sandflies. Existing treatments, such as pentavalent antimony, miltefosine, and Amphotericin B, exhibit limitations. Despite the emergence of liposomal Amphotericin B (AmBisome) as a promising antileishmanial agent, its utility is impeded by adverse effects, elevated production expenses, and cytotoxicity. To address these challenges, our investigation introduces a potential remedy─a citrate-coated gold Amphotericin B nanoparticle formulation. Characterized using dynamic light scattering and transmission electron microscopy, this pioneering formulation exhibited efficacy against Ag83 promastigotes as demonstrated by MTT cell viability testing. Evaluating internal reactive oxygen species (ROS) levels and dual staining with acridine orange and ethidium bromide unveiled its consequential impact on cell death. Significantly, our study discloses this novel nanoformulation's unprecedented inhibition of the trypanothione reductase enzyme. The findings posit the citrate-coated gold Amphotericin B nanoformulation as a promising and targeted antileishmanial agent, representing potential advancements in leishmaniasis therapeutics.

摘要

利什曼病是由原生动物寄生虫引起的,表现为多种临床形式,包括皮肤利什曼病、黏膜皮肤利什曼病和内脏利什曼病;内脏利什曼病构成了重大的全球健康威胁。这种疾病流行于热带和亚热带地区,主要影响贫困线以下的人群,通过雌性沙蝇的叮咬传播。现有的治疗方法,如五价锑、米替福新和两性霉素 B,都存在局限性。尽管出现了脂质体两性霉素 B(AmBisome)作为一种有前途的抗利什曼病药物,但由于其副作用、高昂的生产成本和细胞毒性,其应用受到了限制。为了解决这些挑战,我们的研究提出了一种潜在的治疗方法——柠檬酸涂层金两性霉素 B 纳米颗粒制剂。该制剂采用动态光散射和透射电子显微镜进行了表征,MTT 细胞活力测试表明,该制剂对 Ag83 前鞭毛体具有疗效。评估细胞内活性氧(ROS)水平并用吖啶橙和溴化乙锭双重染色揭示了其对细胞死亡的重大影响。值得注意的是,我们的研究揭示了这种新型纳米制剂对硫氧还蛋白还原酶的前所未有的抑制作用。这些发现表明,柠檬酸涂层金两性霉素 B 纳米颗粒制剂是一种有前途的、有针对性的抗利什曼病药物,为利什曼病的治疗带来了潜在的进展。

相似文献

1
Development of Amphotericin B Decorated Gold Nanoparticles as a Promising Antileishmanial Nanoconjugate.阿霉素修饰的金纳米粒子作为一种有前途的抗利什曼原虫纳米偶联物的研制。
ACS Appl Bio Mater. 2024 Sep 16;7(9):6239-6248. doi: 10.1021/acsabm.4c00835. Epub 2024 Aug 18.
2
Synthesis, characterization, and mechanistic studies of a gold nanoparticle-amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity.金纳米粒子-两性霉素 B 共价缀合物的合成、表征及作用机制研究,该缀合物具有增强的抗利什曼原虫疗效和降低的细胞毒性。
Int J Nanomedicine. 2019 Aug 20;14:6073-6101. doi: 10.2147/IJN.S196421. eCollection 2019.
3
Nanonization increases the antileishmanial efficacy of amphotericin B: an ex vivo approach.纳米化提高两性霉素 B 的抗利什曼原虫疗效:一种离体方法。
Adv Exp Med Biol. 2014;808:77-91. doi: 10.1007/978-81-322-1774-9_7.
4
Isatis tinctoria mediated synthesis of amphotericin B-bound silver nanoparticles with enhanced photoinduced antileishmanial activity: A novel green approach.菘蓝介导合成具有增强光诱导抗利什曼原虫活性的两性霉素B结合银纳米颗粒:一种新型绿色方法。
J Photochem Photobiol B. 2016 Aug;161:17-24. doi: 10.1016/j.jphotobiol.2016.05.003. Epub 2016 May 4.
5
In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.新型N-苄基-1H-苯并咪唑-2-胺衍生物对皮肤、黏膜皮肤和内脏利什曼原虫物种的体外活性。
Exp Parasitol. 2018 Jan;184:82-89. doi: 10.1016/j.exppara.2017.11.009. Epub 2017 Dec 1.
6
Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies.用于治疗内脏利什曼病的胺修饰石墨烯两性霉素B的表征与评价:体内和体外研究
Drug Des Devel Ther. 2014 Sep 4;8:1235-47. doi: 10.2147/DDDT.S63994. eCollection 2014.
7
Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis.载两性霉素 B 和巴龙霉素的改良固体脂质纳米粒:一种有效治疗实验性内脏利什曼病的口服联合药物。
Sci Rep. 2020 Jul 22;10(1):12243. doi: 10.1038/s41598-020-69276-5.
8
Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.两性霉素 B 抑制杜氏利什曼原虫进入原代巨噬细胞。
Biochem Biophys Res Commun. 2010 Aug 27;399(3):429-33. doi: 10.1016/j.bbrc.2010.07.099. Epub 2010 Aug 3.
9
Antimony susceptible : evidence from drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.锑敏感:来自前米替福新时代和后米替福新时代间,从卡拉巴肿后皮肤利什曼病患者分离的寄生虫药物敏感性获得的证据。
Microbiol Spectr. 2024 Jun 4;12(6):e0402623. doi: 10.1128/spectrum.04026-23. Epub 2024 May 7.
10
In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.硫利达嗪对两性霉素B无反应/敏感的杜氏利什曼原虫前鞭毛体和细胞内无鞭毛体的体外抗利什曼活性。
Exp Parasitol. 2024 Feb;257:108688. doi: 10.1016/j.exppara.2023.108688. Epub 2023 Dec 22.

引用本文的文献

1
Kojic Acid Promotes Apoptosis-like Death and Cell Cycle Arrest in () Promastigotes.曲酸促进()前鞭毛体的凋亡样死亡和细胞周期停滞。
ACS Omega. 2025 Aug 11;10(32):36376-36381. doi: 10.1021/acsomega.5c04741. eCollection 2025 Aug 19.